Cargando…
The Response of Variant Histology Bladder Cancer to Intravesical Immunotherapy Compared to Conventional Cancer
BACKGROUND: High-grade urothelial carcinomas (UCs) often show foci of variant differentiation. There is limited information in the literature about the response of these variant urothelial tumors to immunotherapy with bacillus Calmette–Guerin (BCG). We compared the response, to treatment with BCG, o...
Autores principales: | Gofrit, Ofer N., Yutkin, Vladimir, Shapiro, Amos, Pizov, Galina, Zorn, Kevin C., Hidas, Guy, Gielchinsky, Ilan, Duvdevani, Mordechai, Landau, Ezekiel H., Pode, Dov |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791377/ https://www.ncbi.nlm.nih.gov/pubmed/27014622 http://dx.doi.org/10.3389/fonc.2016.00043 |
Ejemplares similares
-
Gross Hematuria in Patients with Prostate Cancer: Etiology and Management
por: Gofrit, Ofer N., et al.
Publicado: (2013) -
Is radical cystectomy mandatory in every patient with variant histology of bladder cancer
por: Shapur, Nandakishore Kamalakar, et al.
Publicado: (2011) -
High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?
por: Mekayten, Matan, et al.
Publicado: (2018) -
The natural history of secondary muscle-invasive bladder cancer
por: Hidas, Guy, et al.
Publicado: (2013) -
The growth rate of “clinically significant” renal cancer
por: Gofrit, Ofer N., et al.
Publicado: (2015)